Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study

The present study aims to further test this cognitive-existential group intervention for FCR in a randomized control clinical trial with women with breast or gynecological cancer. Participants will be recruited from Princess Margaret Hospital, Mount Sinai Hospital, the Jewish General Hospital, and the Ottawa Hospital. 144 cancer patients will be randomized to either receive the 6 week cognitive-existential group intervention or to a control group. The control group will also consist of six weekly sessions during which participants will discuss the challenges of living with a cancer diagnosis, but without a clear focus on FCR. Women randomized to participate in the study will a) be 18 years or older; b) have a first diagnosis of breast or gynecological cancer with stages between IIII; c) be disease free at the start of the group; d) gave clinical levels of fear of cancer recurrence; e) have clinical levels of distress; and f) have completed their cancer treatment.

Inclusion criteria

• first diagnosis of BC or GC with stages between I-III;
• disease-free at the start of the group;
• women aged 18 years or older;
• completion of treatment, with the exception of adjuvant chemotherapy or hormonal replacement therapy

Exclusion criteria

• non-English speakers
• previous cancer recurrence
• enrolled in another group psychotherapy at the time of the start of the study or during the course of the 6 sessions
• unresolved mental health disorder judged to be clinically contra-indicated and/or likely to affect the group work, based on disclosure by the potential participant or clinically identified by the group leader.